$73.69
+9.20 (+14.27%)
Performance
1D
—
1W
—
1M
—
3M
-0.63%
6M
+1.67%
1Y
+66.61%
YTD
-3.97%
Open$74.07
Previous Close$64.49
Day High$79.91
Day Low$69.43
52W High$87.50
52W Low$37.94
Volume—
Avg Volume1.42M
Market Cap5.85B
P/E Ratio8.57
EPS$7.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.08
Below
SMA 200
$61.55
Above
RSI (14)
25.1
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
21 analysts
Price Target
+5.8% upside
Current
$73.69
$73.69
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.56B | 1.15B | 623.61M |
| Net Income | 613.86M | 408.33M | 103.27M |
| Profit Margin | 39.4% | 37.5% | 16.6% |
| EBITDA | 795.72M | 558.71M | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +35.3% | +35.3% | +11.8% |
| Debt/Equity | 848.93 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |